-
Turkey
Creek Water Buffalo
Home Buffalo in the News Breeding Information Buffalo - Mozzarella Cheese WB Links
WB Meat Water Buffalo Pictures Water Buffalo Stories WB Types
WB Bulls WB Heifers WB - Milking Master Page Water Buffalo Semen
Interesting news :
Udderly
New Insight About Milk and Autism: An Emerging New Hypothesis on A1 and A2
Beta-Casein
February 8, 2011 Categories: Autism News, Food &
Nutrients, Scientific Research by Julie Matthews 5 Comments
Reposted from December 31, 2008, NourishingHope.com
By Julie Matthews, Certified Nutrition Consultant
As an autism nutrition consultant, I’ve been supporting
clients following the Gluten-Free Casein-Free (GFCF) diet for years.
Some of my clients would report that their child could handle goat’s
milk or raw milk without allergic reactions. I began to wonder if all milk was
created equally.
I conjured various theories: could the protein in goat’s
milk be different than cow milk, was it the pasteurization process (absent in
raw milk) that made the difference, was it something else, or a combination of
factors? Then, one of my clients
introduced me to A1 and A2 beta-casein.
There are various types of casein.
Goat’s milk, as well as sheep and buffalo milk, contain A2 beta-casein.
Raw milk, while often from cows, is typically produced from small herds of
Jersey and Gernsey cows, both of which contain a high percentage of A2
beta-casein compared to most dairies that use mainly Holstein cow’s that
produce a majority of A1 beta-casein. Here’s
what I have learned through my research about casein and A1 versus A2
beta-casein.
Beta-casein is a protein that contains bioactive peptides
and opioids. Bioactive peptides are important for protecting the undeveloped
immune system of newborns, and stimulate the growth and development of organs
like the gastrointestinal tract and gut. Bioactive peptides have also been shown
to kill bacteria that normally cause immune system infections. Opioids have
pain-killing effects, sedative properties, induce sleep, and play a role in the
control of food intake. Opioids can be produced by the body in the form of
endorphins, or be absorbed from digested food, such as milk and wheat, in the
form of casomorphins and gluteomorphins (opioid proteins). Several forms of
beta-casein exist and make up 25-30% of the proteins in cow’s milk. There are
approximately 13 beta-casein variants, with A1 and A2 variants being the most
commonly occurring. A1 beta-casein contains the amino acid histidine at position
67 in the protein, while A2 beta-casein instead contains the amino acid proline
at the same position. Studies have shown that when digested, A1 beta-casein
breaks down to a casomorphin protein called beta-casomorphin-7 (BCM7). This is a
direct result of the histidine amino acid that A1 beta-casein contains, as A2
beta-casein does not form BCM7 (1).
Several enzymes in the digestive tract process beta-casein
including DPPIV, (dipeptidyl peptidase IV) and cause the break down of bioactive
peptides and opioids. Studies suggest that the digestion of cow’s milk
(containing A1 beta-casein), leads to the release of opioids, such as BCM7, and
can cause harmful effects in children with autism (2) where DPPIV function may
be impaired. As this amino acid
structure is more difficult to breakdown, those with compromised or weak
digestion may accumulate opioids more readily. Additionally, when the gut is
“leaky” (referring to increased gut permeability), these opioids end up in
the blood stream in much greater concentrations than in those people with a
healthy gut wall that does not leak. BCM7 is not produced when A2 beta-casein is
digested, so goat’s, buffalo’s, and sheep’s milk that contain A2
beta-casein but not A1 beta-casein should not cause these harmful effects. There
are other opioids that may also be formed; however, BCM7 appears to be the
strongest.
As Jon Pangborn, Ph.D. describes, the enzyme DPPIV, which
is also called CD26, has several other functions in the body, including
involvement in signal transmission via lymphocyte receptors, and assisting the
enzyme, ADA, in processing adenosine as an ADA binding protein. DPPIV is
impaired by toxic heavy metals like mercury, lead and cadmium, a milk allergy,
organophosphate insecticides, and yeast. Children with autism have greater toxic
metal burdens, and one theory is that these heavy metals knock out this DPPIV
enzyme, and the impaired DDPIV leads to improper processing of dairy and wheat.
A supplemented plant analog version of DPPIV cannot substitute for the animal
version completely, but it can certainly help.
While it is possible that A2 milk may also release opioids,
Japanese and German scientists were unable to release BCM7 from A2 milk (1, 3).
It appears that human breast milk may not release BCM7 either. Interestingly,
this may explain why breastfeeding does not seem to cause a casein reaction to
sensitive babies when dairy is avoided in a mother’s diet. In addition to
affecting autism, research suggests that BCM7 may lead to the onset of several
diseases, such as heart disease, diabetes, and schizophrenia (4).
Studies have also shown that wheat products, which contain
gluten, also cause health problems for children with autism (5)
Gluten has long been established as a problematic protein for many
individual, most well studied in celiac patients, causing inflammation in the
gut, diarrhea, constipation, abdominal pain, digestive problems, and the
improper absorption of nutrients. Similar
responses are seen in many children with autism (that are not diagnosed with
celiac). Gluten, along with an
autistic person’s already compromised digestive system, can exacerbate the
ability of the body to break down beta-casein.
Scientists believe that opioids like gliadomorphin (a
gluten opioid) and BCM7 (a casein opioid) are toxic for children with autism due
to the fact that these children have an abnormal, leaky, gastrointestinal tract
(6). Instead of completely digesting and excreting these opioid proteins, some
of the partially digested gluten and casein proteins leak out of the gut and are
transported to other parts of the body before they can be completely digested.
These opioid proteins travel through the bloodstream, cross the blood brain
barrier (the barrier between the brain and the rest of the body), enter the
brain, and stimulate morphine-like effects. Casein proteins (BCM7) negatively
affect the brain by causing inattentiveness, unclear thinking, and irregular
sleeping and eating patterns (7).
In children with autism, gliadomorphin and BCM7 can also
cause the release of histamine, a chemical that regulates immune cell
communication. Histamines are normally released in the body in response to an
allergic reaction. This mis-regulation of immune cells weakens the immune
system’s ability to ward off harmful viruses and bacteria that cause diseases.
This is consistent with the experience that many children with autism get
frequent infections and illness.
Antibodies are also released to help target and remove
unwanted opioid proteins. IgA is an antibody that can be found in blood, saliva,
tears, and mucous membranes of the respiratory system and gastrointestinal
tract. IgG antibodies are the most common antibodies in the body, and can be
located in all bodily fluids. IgG antibodies are the only form of antibody that
can cross the placenta in pregnant woman to protect a fetus (unborn baby). IgG
antibodies also play a major role in fighting viral and bacterial infections.
When the immune system detects foreign particles such as viruses, bacteria,
fungi, or cancer cells it stimulates the production and release of antibodies.
These antibodies attach to the foreign particles, labeling them as hazardous so
that they can be destroyed and removed from the body (8). So while the peptides
from casein or gluten trigger an IgG immune response, the opioids trigger an IgA
immune response. So it is not just opioids that trigger an immune response,
casein and gluten protein can do so also, just using different types of
antibodies.
Studies have shown that in autistic and schizophrenic
patients, large amounts of gliadomorphin and BCM7 can be detected outside the
gut (8). This further indicates that their bodies are not able to properly break
down and utilize these opioid proteins. These studies also showed that in 86% of
schizophrenic patients, IgA antibodies that were targeting gluten were released
into the body, and 67% had IgA antibodies that were targeting casein. In
patients with autism, approximately 30% of the patients had IgA antibodies
targeting gluten and casein present in the body. The release of IgG antibodies
targeting gluten and casein were also detected in these patients. More than 80%
of the autistic and schizophrenic patients had elevated levels of IgG antibodies
in their blood.
In recent years, the adverse
effects of gluten and casein led researchers and to believe
that autistic and schizophrenic patients should be placed on a
gluten-free/casein-free diet, and this has become a widespread treatment for
both diseases (9). Case studies that involved putting patients with
schizophrenia and autism on a gluten-free/casein-free diet normally lead to some
improvement of symptoms, but more clinical trials need to be performed to get a
better picture of why this is the case. There is not enough data yet to
understand all of the complexity behind gluten and casein and the challenges
with them, but the experience of thousands of patients support the science we
know so far: that a gluten-free/casein-free diet helps. And of course
implementing the diet always depends on the patient’s needs, the caregiver’s
willingness to try it, and professional supervision (10).
Schizophrenic patients who were put on a
gluten-free/casein-free diet or treated with dialysis, a process that cleans the
blood in order to rid the body of gliadomorphin and BCM7, were relieved of their
symptoms, and low levels of the opioid proteins were detected. Approximately 81%
of patients with autism who were put on a gluten-free/casein-free diet for at
least 3 months were also relieved of their symptoms. A few parents, who stated
that their child with autism had seizures before going on the diet, noticed that
the frequency of the seizures either decreased or ceased all together. As
previously stated, opioid proteins can cause an allergic response in the body,
which leads to the release of histamines. Histamines have a direct effect on
immune cell regulation. The disturbed immune response leads to a higher
production of antibodies, such as IgA and IgG, as a means of further breaking
down and excreting harmful gliadomorphin and BCM7 particles. In other words, the
high levels of antibodies that are detected in patients with autism are a direct
result of complications that occur when gluten and A1 beta-casein are consumed
(8).
A vast majority of children that consume dairy consume cow
milk products so removal of dairy on the GFCF diet would be the removal of A1
beta-casein in most instances. This may be the reason the GFCF diet is so
successful for children on the autism spectrum.
I’d like to pose a new hypothesis, maybe it is not ALL casein but the
A1 beta-casein that is actually the primary problem with milk for children with
autism.
With that said, there are most likely are other reactions
and problems with dairy for some (if not many) individuals, so I do not think
this preliminary information justifies abandoning the GFCF diet.
(In fact, I hesitated writing and talking about this topic for a long
time, as I did not want to confuse parents new to diet.)
I have seen many wonderful results from GFCF and know many clients that
cannot seem to tolerate goat or raw dairy. I
don’t want children to miss out of the full benefit from diet by not trying a
GFCF diet.
Through my clinical experience, I have found that it is
very important to give the GFCF diet a complete trial, free of any infractions.
Once a child has been on this diet for 3-6 months and you see what
progress can be made with it, then and only then, do I feel that a parent may
experiment with diet and try adding goat’s milk or some other A2 milk back.
It seems that for some children, their casein sensitivity is mild and A2
milk works well. For others, once
the gut is healed, they are able to consume small amounts of A2 milk.
I often hear that as a child’s digestive systems improve, they are able
to handle goat’s milk yogurt or raw milk. It is possible that the BCM7 issue
is a primary factor for some people, and that A2 milk may provide an option for
some individuals.
While milk is not “necessary” in the diet, dairy has
health benefits when the individual is not intolerant to it.
(Note that when people are intolerant, it can be very harmful regardless
of the “benefits.”) If there is
a way to include some dairy in some children’s diets, there can be a positive
benefit to having this flexibility and nutrition in the diet.
Dairy makes wonderful probiotic-rich fermented foods such as yogurt and
kefir to support a healthy intestinal tract—and often nuts, nut milk and
coconut-based fermentations are not tolerated.
Dairy contains essential fatty acids, fat-soluble vitamins A, D, and K,
and calcium. Additionally, as I
describe in Nourishing Hope for Autism, butyrate, (also butyric acid), found in
dairy, “has been shown to clear ammonia and nitrogen, modulate local
electrolyte flux, supports the reduction of diarrhea and improves very large,
hard stools. Butyric acid also supports and fuels the intestinal walls to
support a healthy gut and is used as an anti-candida substance.”
Raw dairy contains phosphatase (an enzyme important for calcium
absorption), probiotics, unadulterated protein, and higher nutritional content
(because of what is normally destroyed during pasteurization and because they
are pasture-grazed). This new A1 and
A2 information may allow some children with autism to receive the benefits of
milk without the problems it can cause.
Please share your experience with A2 milk.
References
1. Jinsmaa Y, Yoshikawa M. (1999) Enzymatic release of
neocasomorphin and beta-casomorphin from bovine beta-casein. Peptides,
20:957-962.
2. Reichelt KL, Knivsberg AM, Lind G, Nodland M: Probable
etiology and possible treatment of childhood autism. Brain Dysfunction 1991; 4:
308-319.
3. Hartwig A, Teschemacher H, Lehmann W, Gauly M, Erhadt G.
(1997) Influence of genetic polymorphism in bovine milk on the occurence of
bioactive peptides. In: Milk Protein Polymorphism, International Dairy
Federation Special Publication, Brussels, Belgium. 9702 :459-460.
4. Kamiński S, Cieslińska A, Kostyra E. (2007)
Polymorphism of bovine beta-casein and its potential effect on human health. The
Journal of Applied Genetics, 48(3):189-198.
5. Jyonouchi H,
Geng L, Ruby A, Reddy C, Zimmerman-Bier B. (2005) Evaluation of an association
between gastrointestinal symptoms and cytokine production against common dietary
proteins in children with autism spectrum disorders. J Pediatr.
May;146(5):582-4.
6. Shattock P, Whiteley P. (2002) Biochemical aspects in
autism spectrum disorders: updating the opioid-excess theory and presenting new
opportunities for biomedical intervention. Expert Opin Ther Targets.
Apr;6(2):175-83
7. Sun Z, Zhang Z, Wang X, Cade R, Elmer Z, Fregly M.
(2003) Relation of beta-casomorphin to apnea in sudden infant death syndrome.
Peptides, 24:937–943.
8. Cade R, Privette R, Fregly M, Rowland N, Sun Z, Zele V.
(2000) Autism and schizophrenia: intestinal disorders. Nutritional Neuroscience,
3: 57–72.
9. Knivsberg AM, Reichelt KL, Nodland M. (2001) Reports on
dietary intervention in autistic disorders. Nutritional Neuroscience,
4(1):25-37.
10. Knivsberg AM, Reichelt KL, Hoien T, Nodland M. (2002) A
randomised, controlled study of dietary intervention in autistic syndromes.
Nutritional Neuroscience, 5(4):251-61.
Originally published December 31, 2008.
Republished February 2011.
|
Phone: 870-645-2595 07/12/2023 The Turkey Creek Corporation - All Rights Reserved 2023 © |
|
|